Funding Friday: Brickell prepares to sell $50M in new stock, more SPACs launch
Welcome to Funding Friday, BizWest’s roundup of companies in Northern Colorado and the Boulder Valley kicking off fundraisers.
BizWest reports fundraisers by companies in Boulder, Broomfield, Larimer and Weld counties, as well as Brighton and Westminster through regulatory filings, press releases and other sources. Did we miss a company’s round? Email us at news@bizwest.com.
Notable rounds this week:
- Brickell Biotech Inc. (Nasdaq: BBI) said it would sell up to $50 million in new stock in an on-demand at-market-price offering. The funds are meant to bolster the company’s balance sheet as it completes two Phase III trials for its flagship anti-underarm sweating treatment…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Related Posts
-
Medical-device firm Boulder iQ has nearly doubled its Boulder footprint with the purchase of a…
-
Edgewise Therapeutics Inc., a Boulder-based muscle disease biopharmaceutical company, increased its research and development spending…
-
OnKure Inc., a Boulder precision oncology company, and California-based Reneo Pharmaceuticals Inc. have completed a…
-
Mosaic Biosciences Inc., a Boulder drug-discovery company that provides protein and antibody therapeutics research to…
